Chest physicians' and microbiologists' awareness and demand for drug monitoring in the treatment of TB.

S. Pooransingh*, E. G. Smith, J. A. Innes

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

There is a role for therapeutic drug monitoring (TDM) to achieve the optimum therapeutic concentration of anti-tuberculous drugs. This work aimed to determine the current awareness of TDM in TB control among chest physicians and to estimate the demand for this service. Responses from a sample of chest physicians in the West Midlands revealed that 60% were aware of TDM and 33% had used it. Responses were received from half of a UK group of microbiologists who reported a median of nine requests in the past year. It appeared that more was known about services for rifampicin and streptomycin than other first-line drugs. There appears to be a need for both increased awareness among potential service users and for coordination of assay services.

Original languageEnglish
Pages (from-to)317-319
Number of pages3
JournalCommunicable disease and public health / PHLS
Volume6
Issue number4
Publication statusPublished - Dec 2003
Externally publishedYes

Fingerprint

Dive into the research topics of 'Chest physicians' and microbiologists' awareness and demand for drug monitoring in the treatment of TB.'. Together they form a unique fingerprint.

Cite this